A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Cystic Fibrosis

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcf.2015.10.014PMID 26610860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis.

  2015cited by this paper
• Utilization of antibiotics for methicillin‐resistant Staphylococcus aureus infection in cystic fibrosis

  2015cited by this paper
• Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis.

  2014cited by this paper
• Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.

  2013cited by this paper
• Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.

  2013influential reference
• Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.

  2012cited by this paper
• Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.

  2011cited by this paper
• Review: Staphylococcus aureus and MRSA in cystic fibrosis.

  2011cited by this paper
• The impact of MRSA infection in the airways of children with cystic fibrosis; a case-control study.

  2011cited by this paper
• A SAS® macro implementation of a multiple comparison post hoc test for a Kruskal-Wallis analysis

  2011cited by this paper
• Treatment intensity and characteristics of MRSA infection in CF.

  2011cited by this paper
• Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide

  2010cited by this paper
• Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

  2010cited by this paper
• Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

  2009cited by this paper
• Pulmonary Complications of Cystic Fibrosis

  2009cited by this paper
• The impact of MRSA on lung function in patients with cystic fibrosis.

  2009cited by this paper
• Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.

  2008cited by this paper
• Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre

  2006cited by this paper
• Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria

  2006cited by this paper
• Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa

  2006cited by this paper
• Lung function decline in cystic fibrosis patients and timing for lung transplantation referral.

  2004cited by this paper
• Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

  2003cited by this paper
• Spirometric reference values from a sample of the general U.S. population.

  1999cited by this paper
• Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years.

  1993cited by this paper
• Pulmonary function between 6 and 18 years of age

  1993cited by this paper

• Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of “aged” people with cystic fibrosis

  2026cites this paper
• Pseudomonas aeruginosa Biofilms: Pathogenicity, Clinical Challenges and Emerging Therapeutic Strategies

  2025cites this paper
• Engineered Mycoplasma pneumoniae targeting dual-species bacterial biofilms: a novel strategy against infections

  2025cites this paper
• Evolution and Prognostic Variables of Cystic Fibrosis in Children and Young Adults: A Narrative Review

  2025cites this paper
• Pathogen-pathogen interactions during co-infections

  2025cites this paper
• Contributions of β-lactamase substrate specificity and outer membrane permeability to the antibiotic sheltering of β-lactam-susceptible bacteria

  2025cites this paper
• Calprotectin elicits aberrant iron starvation responses in Pseudomonas aeruginosa under anaerobic conditions

  2025cites this paper
• Assessment of the efficacy of an antimicrobial peptide in the context of cystic fibrosis airways

  2025cites this paper
• Mutations in the Staphylococcus aureus Global Regulator CodY confer tolerance to an interspecies redox-active antimicrobial

  2025cites this paper
• Logic programming-based Minimal Cut Sets reveal consortium-level therapeutic targets for chronic wound infections

  2024cites this paper
• Impact of mixed Staphylococcus aureus-Pseudomonas aeruginosa biofilm on susceptibility to antimicrobial treatments in a 3D in vitro model

  2024cites this paper
• Chronic co-infection with Pseudomonas aeruginosa and normal colony Staphylococcus aureus causes lung structural damage in the cystic fibrosis rat.

  2024cites this paper
• Pseudomonas aeruginosa surface motility and invasion into competing communities enhance interspecies antagonism

  2024cites this paper
• Mutations in the Staphylococcus aureus Global Regulator CodY Confer Tolerance to an Interspecies Redox-Active Antimicrobial

  2024cites this paper
• Histoplasmosis y bacteremia persistente por Staphylococcus aureus meticilino-resistente asociada a derivación ventriculoperitoneal: reporte de caso

  2024cites this paper
• Mucin-induced surface dispersal of Staphylococcus aureus and Staphylococcus epidermidis via quorum-sensing dependent and independent mechanisms

  2024cites this paper
• Pseudomonas aeruginosa surface motility and invasion into competing communities enhances interspecies antagonism

  2024cites this paper
• The type IV pilus chemoreceptor PilJ controls chemotaxis of one bacterial species towards another

  2024cites this paper
• Citrate cross-feeding by Pseudomonas aeruginosa supports lasR mutant fitness

  2024cites this paper
• The Impact of Staphylococcus aureus on Biofilm, Antibiotic Resistance and Cytotoxicity of Pseudomonas aeruginosa Isolated from Mixed Wound Infections

  2023cites this paper
• Extracellular vesicles of Pseudomonas aeruginosa downregulate pyruvate fermentation enzymes and inhibit the initial growth of Staphylococcus aureus

  2023cites this paper
• Nutrient Limitation Sensitizes Pseudomonas aeruginosa to Vancomycin

  2023cites this paper
• Role of Pel and Psl polysaccharides in the response of Pseudomonas aeruginosa to environmental challenges: oxidative stress agents (UVA, H2O2, sodium hypochlorite) and its competitor Staphylococcus aureus

  2023cites this paper
• Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa

  2023cites this paper
• Characterisation of key genotypic and phenotypic traits of clinical cystic fibrosis Staphylococcus aureus isolates.

  2023cites this paper
• Staphylococcus aureus and Pseudomonas aeruginosa Isolates from the Same Cystic Fibrosis Respiratory Sample Coexist in Coculture

  2022cites this paper
• Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review

  2022cites this paper
• Subinhibitory Cefotaxime and Levofloxacin Concentrations Contribute to Selection of Pseudomonas aeruginosa in Coculture with Staphylococcus aureus

  2022cites this paper
• Systematic identification of molecular mediators of interspecies sensing in a community of two frequently coinfecting bacterial pathogens

  2022cites this paper
• Characterisation of key genotypic and phenotypic traits of clinical cystic fibrosis Staphylococcus aureus isolates

  2022cites this paper
• Twitching cells use a chemoreceptor to detect bacterial competitors

  2022cites this paper
• Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.

  2022cites this paper
• Interactions between metabolism and growth can determine the co-existence of Staphylococcus aureus and Pseudomonas aeruginosa

  2022cites this paper
• Antibiotics and outcomes of CF pulmonary exacerbations in children infected with MRSA and Pseudomonas aeruginosa.

  2022cites this paper
• Single-Cell Imaging Reveals That Staphylococcus aureus Is Highly Competitive Against Pseudomonas aeruginosa on Surfaces

  2021cites this paper
• Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract

  2021cites this paper
• Clinical Implications of Polymicrobial Synergism Effects on Antimicrobial Susceptibility

  2021cites this paper
• Antibiotic intervention redisposes bacterial interspecific interacting dynamics in competitive environments.

  2021cites this paper
• Pseudomonas aeruginosa, the type of mutation, lung function, and nutritional status in adults with cystic fibrosis.

  2021cites this paper
• Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.

  2021cites this paper
• Untargeted Metabolomics Reveals Species-Specific Metabolite Production and Shared Nutrient Consumption by Pseudomonas aeruginosa and Staphylococcus aureus

  2021cites this paper
• Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome Model

  2021cites this paper
• Multidimensional Clinical Surveillance of Pseudomonas aeruginosa Reveals Complex Relationships between Isolate Source, Morphology, and Antimicrobial Resistance

  2021cites this paper
• Rapid and strain-specific resistance evolution of Staphylococcus aureus against inhibitory molecules secreted by Pseudomonas aeruginosa

  2021cites this paper
• Systematic identification of molecular mediators underlying sensing of Staphylococcus aureus by Pseudomonas aeruginosa

  2021cites this paper
• Suppressing Alpha-Hemolysin as Potential Target to Screen of Flavonoids to Combat Bacterial Coinfection

  2021cites this paper
• Pseudomonas aeruginosa enhances the efficacy of norfloxacin against Staphylococcus aureus biofilms

  2020cites this paper
• Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?

  2020cites this paper
• Cystic fibrosis microbiome: analysis of nasal middle meatus and sputum in different lung disease stages

  2020cites this paper
• Pseudomonas aeruginosa Biofilms

  2020cites this paper
• Strain Background, Species Frequency, and Environmental Conditions Are Important in Determining Pseudomonas aeruginosa and Staphylococcus aureus Population Dynamics and Species Coexistence

  2020cites this paper
• Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis.

  2020cites this paper
• Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms

  2020cites this paper
• Strain background, species frequency and environmental conditions are important in determining population dynamics and species co-existence between Pseudomonas aeruginosa and Staphylococcus aureus

  2020cites this paper
• Impact of Coexistence Phenotype Between Staphylococcus aureus and Pseudomonas aeruginosa Isolates on Clinical Outcomes Among Cystic Fibrosis Patients

  2020cites this paper
• Impact of biotic and abiotic factors on competitive interactions between 1 Pseudomonas aeruginosa and Staphylococcus aureus 2

  2020cites this paper
• Prevalence of Methicillin-Resistant Staphylococcus Aureus (MRSA) infection in patients with Cystic Fibrosis: a meta-analysis

  2019cites this paper
• Interspecies interactions induce exploratory motility in Pseudomonas aeruginosa

  2019cites this paper
• Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation

  2019cites this paper
• Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis

  2019cites this paper
• “It Takes a Village”: Mechanisms Underlying Antimicrobial Recalcitrance of Polymicrobial Biofilms

  2019cites this paper
• Intermittent colonisation with Methicillin-Resistant Staphylococcal aureus can be eradicated from the Airways of Adults with Cystic Fibrosis

  2019cites this paper
• Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics

  2019cites this paper
• Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure.

  2019cites this paper
• Interspecies signaling generates exploratory motility in Pseudomonas aeruginosa

  2019cites this paper
• Anaerobiosis influences virulence properties of Pseudomonas aeruginosa cystic fibrosis isolates and the interaction with Staphylococcus aureus

  2019cites this paper
• Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study

  2019cites this paper
• Pseudomonas aeruginosa and Staphylococcus aureus during respiratory infections ?

  2019cites this paper
• Transcriptional profiling of Pseudomonas aeruginosa and Staphylococcus aureus during in vitro co-culture

  2019cites this paper
• Contact lens-related corneal infection: Intrinsic resistance and its compromise.

  2019cites this paper
• Pseudomonas aeruginosa Quorum-Sensing and Type VI Secretion System Can Direct Interspecific Coexistence During Evolution

  2018cites this paper
• Interaction between Staphylococcus aureus and Pseudomonas aeruginosa is 1 beneficial for colonisation and pathogenicity in a mixed-biofilm 2 3

  2018cites this paper
• Interaction between Staphylococcus aureus and Pseudomonas aeruginosa is beneficial for colonisation and pathogenicity in a mixed biofilm

  2018cites this paper
• Antibacterial activity of extracts of Stevia rebaudiana Bertoni against Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa

  2017cites this paper
• Mechanisms of Pyocyanin Toxicity and Genetic Determinants of Resistance in Staphylococcus aureus

  2017cites this paper
• Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients

  2017cites this paper
• Evaluation of the Risk for Acute Kidney Injury in Adult Cystic Fibrosis Patients Receiving Concomitant Vancomycin and Tobramycin

  2017cites this paper
• Pseudomonas aeruginosa Alginate Overproduction Promotes Coexistence with Staphylococcus aureus in a Model of Cystic Fibrosis Respiratory Infection

  2017cites this paper
• [Infections in cystic fibrosis: Up-to-date].

  2016cites this paper
• Short-term response and long-term adaptation of Pseudomonas aeruginosa to co-colonizing bacterial species

  2016cites this paper
• Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections

  2016cites this paper
• Understanding the natural history and clinical implications of airways infections in CF - Moving beyond the classics.

  2016cites this paper